Active Ingredient History
Cetirizine, a human metabolite of hydroxyzine, is an antihistamine; its principal effects are mediated via selective inhibition of peripheral H1 receptors. It is indicated for the relief of nasal and non-nasal symptoms associated with seasonal or perennial allergic rhinitis, hay fever and chronic idiopathic urticaria. Commonly reported adverse reactions of cetirizine include headache, dry mouth and drowsiness or fatigue. Pharmacokinetic interaction studies with Cetirizine in adults were conducted with pseudoephedrine, antipyrine, ketoconazole, erythromycin and azithromycin. No interactions were observed. NCATS
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
Combination drugs
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Alopecia (Phase 4)
Altitude Sickness (Phase 4)
Asthma (Phase 4)
Breast Neoplasms (Phase 3)
Chronic Urticaria (Phase 2)
Conjunctivitis, Allergic (Phase 2)
COVID-19 (Phase 4)
Dermatitis (Phase 3)
Dermatitis, Atopic (Phase 3)
Diabetes Mellitus, Type 2 (Phase 4)
Diabetic Neuropathies (Phase 4)
Eczema (Phase 3)
Endometrial Neoplasms (Phase 3)
Esophageal Neoplasms (Phase 3)
Exercise (Phase 4)
Head and Neck Neoplasms (Phase 3)
Healthy Volunteers (Phase 1)
Hypersensitivity (Phase 4)
Lung Neoplasms (Phase 3)
Migraine Disorders (Phase 1)
Multiple Sclerosis (Phase 4)
Multiple Sclerosis, Relapsing-Remitting (Phase 4)
Neoplasms (Phase 2)
Neuralgia (Phase 4)
Neuromyelitis Optica (Phase 1/Phase 2)
Otitis Media with Effusion (Phase 4)
Ovarian Neoplasms (Phase 3)
Pemphigus (Phase 3)
Prostatitis (Early Phase 1)
Pruritus (Phase 4)
Rhinitis, Allergic (Phase 4)
Rhinitis, Allergic, Perennial (Phase 4)
Rhinitis, Allergic, Seasonal (Phase 4)
Urticaria (Phase 4)
Uterine Cervical Neoplasms (Phase 3)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue